Pfizer ($PFE) Insider Trading & Smart Money Activity

Pfizer Inc. · Drug Manufacturers - General · Latest filing Oct 16, 2026

Pfizer Inc. ($PFE) has 5 insider trades, 5 congress trades, 8 13F position changes and 1 analyst rating on file. Insiders filed 5 Form 4 transactions in the last 12 months, none of them open-market purchases or sales.

Insider buyers (12 mo)
0
Insider sellers (12 mo)
0
Net insider $ (12 mo)
$0
Congress trades (12 mo)
2
13F moves on file
8
Analyst ratings on file
1

PFE insider buying and selling by quarter

QuarterInsider buysInsider salesCongress buys / sales13F added / cut
Q1 2026 0 0 0 / 1 2 / 0
Q2 2026 0 0 0 / 1 2 / 0
Q3 2026 0 0 0 / 0 0 / 0
Q4 2026 0 0 0 / 0 3 / 1

Insider buys and sales count open-market trades only (Form 4 codes P and S). Grants, option exercises and tax withholding are left out.

All PFE insider, congress, 13F and analyst activity

DateSourceWhoActionSharesValue / amount ΔOwn1W1M6MFilingStory
13F Forbes J M Added +221 sh $500.04K —
13F HCR Wealth Advisors New +9.28K sh $264.60K —
13F Goldstein Advisors New +13.63K sh $388.67K —
13F Community Trust & Investment Reduced -10.43K sh $3.26M —
Analyst Scotiabank Reiterates to Sector Outperform PT $33 +3.2% —
Insider Cyrus Taraporevala Buy (Grant or award) 1.54K sh $37.50K -2.3%+3.4% Read
Insider James Quincey Buy (Grant or award) 1.59K sh $38.74K -2.3%+3.4% Read
Insider Shantanu Narayen Buy (Grant or award) 2.06K sh $50.01K -2.3%+3.4% Read
Insider Joseph Echevarria Buy (Grant or award) 1.90K sh $46.25K -2.3%+3.4% Read
Insider Albert BourlaChairman & CEO Buy (Grant or award) 23 sh $598 -3.5%-4.5% —
Congress Tommy Tuberville Sale $15,001 - $50,000 +1.5%-6.1% —
13F Brandes Investment Partners Added +478.04K sh $221.94M +2.2%+2.7% Read
13F Brandes Investment Partners Added +478.04K sh $240.39M +2.2%+2.7% Read
Congress Alan Armstrong Sale $50,001 - $100,000 +4.1%-1.1%+7.1% —
13F Brandywine Global Investment Management Added +1.25M sh $71.67M -1.3%-4.1%-1.9% —
13F Brandywine Global Investment Management Added +1.25M sh $75.43M -1.3%-4.1%-1.9% —
Congress Carol D. Miller Sale $15,001 - $50,000 —
Congress Michael A. Rulli Sale $1,001 - $15,000 —
Congress Tommy Tuberville Sale $15,001 - $50,000 —

1W / 1M / 6M = how PFE moved from the trade or filing date.

Insider trading in PFE: who is buying and selling

InsiderRoleTradesOpen-market netShares heldLast trade
Cyrus Taraporevala 1 — Jun 26, 2026
James Quincey 1 — Jun 26, 2026
Shantanu Narayen 1 — Jun 26, 2026
Joseph Echevarria 1 — Jun 26, 2026
Albert Bourla Chairman & CEO 1 — Jun 15, 2026

Members of Congress trading PFE

Institutions moving PFE (13F)

Analyst ratings on PFE

DateFirmActionRatingPrice target1W1M6MStory
Scotiabank Reiterates Sector Outperform $30 → $33 +3.2% —

Frequently asked questions

What is the latest insider trade in PFE?

Cyrus Taraporevala filed a buy (grant or award) of 1.54K sh worth $37.50K on Jun 26, 2026.

Which members of Congress traded PFE?

5 disclosed trades by Tommy Tuberville, Alan Armstrong, Carol D. Miller and Michael A. Rulli. The latest was on Jun 8, 2026.

Which institutions changed their PFE positions?

Recent 13F filers moving the stock include Brandes Investment Partners, Brandywine Global Investment Management, Forbes J M, HCR Wealth Advisors and Goldstein Advisors.

Other drug manufacturers - general stocks

Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.

Get trade alerts by text